Goodman Noah bought KYMR
June 22, 2026 · Form 4 insider transaction
Goodman Noah bought 2,500 shares of Kymera Therapeutics, Inc. at $21.05 per share, a transaction worth $52.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$21.05
Total value
$52.6K
InsiderGoodman Noah
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 22, 2026
Filing dateJune 22, 2026
Shares owned after52,695
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.